Bioadhesive Berry Gel

Bioadhesive Berry Gel Product for Treatment of Oral Epithelial Dysplasia NanoMed, in collaboration with researchers at The Ohio State University and its James Cancer Hospital and Solove Research Institute, will evaluate the Bioadhesive Berry Gel product in 20 patients with oral lesions in a Phase I/Ia study to begin in December 2005. The objective of this study is to investigate the chemotherapeutic efficacy of local application of the Bioadhesive Berry Gel to induce regression, prevent recurrence, and inhibit progression in persons with oral epithelial dysplasia.